Momelotinib in myelofibrosis: JAK1/2 inhibitor with a role in treating and understanding the anemia.
about
The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells.Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade.The Relative Bioavailability, Food Effect, and Drug Interaction With Omeprazole of Momelotinib Tablet Formulation in Healthy Subjects.Pharmacokinetics and Safety of Momelotinib in Subjects With Hepatic or Renal Impairment.
P2860
Momelotinib in myelofibrosis: JAK1/2 inhibitor with a role in treating and understanding the anemia.
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Momelotinib in myelofibrosis: ...... and understanding the anemia.
@ast
Momelotinib in myelofibrosis: ...... and understanding the anemia.
@en
type
label
Momelotinib in myelofibrosis: ...... and understanding the anemia.
@ast
Momelotinib in myelofibrosis: ...... and understanding the anemia.
@en
prefLabel
Momelotinib in myelofibrosis: ...... and understanding the anemia.
@ast
Momelotinib in myelofibrosis: ...... and understanding the anemia.
@en
P2860
P356
P1433
P1476
Momelotinib in myelofibrosis: ...... and understanding the anemia.
@en
P2093
Elliott F Winton
Vamsi Kota
P2860
P304
P356
10.2217/FON-2016-0417
P407
P577
2016-10-27T00:00:00Z